Lys-Pro-Val
Lysine-Proline-Valine: Tripeptide Structure and Short-Peptide Research
Lysine-Proline-Valine is a three-residue peptide defined by amino-acid sequence, charge and structural properties.
A three-residue sequence
Lysine-Proline-Valine is a tripeptide composed of three amino-acid residues in a defined order. It can be written as Lys-Pro-Val using three-letter amino-acid notation, or KPV using one-letter notation.
Short peptides are sequence-specific materials. Moving, replacing or removing one residue can change charge, shape, solubility and enzyme sensitivity.
Research-use only: the material is supplied for laboratory research, not for human or veterinary administration.
What each residue contributes
Lysine contains a positively charged side chain under many conditions. Proline has a cyclic structure that can restrict backbone flexibility. Valine has a hydrophobic side chain.
Together, those residues create a compact peptide with mixed chemical character: charged, conformationally constrained and hydrophobic elements all appear in a three-residue sequence.
Research material identity
Lysine-Proline-Valine is identified primarily by sequence. The full name, Lys-Pro-Val and KPV all refer to the same residue order when written in standard amino-acid notation.
Tripeptides are commonly supplied as research materials in vial form, often as dry material depending on formulation and supplier.
Research-use boundary
Unauthorized human-use risk context
This section is a safety boundary, not application guidance. The material is not supplied for human or veterinary administration, and the points below do not describe expected effects or acceptable use.
- Research-use material has not been supplied as a finished pharmaceutical product, so unauthorized human use can involve unknown identity, impurity, sterility, immune-response and contamination risks.
- Even short peptides can carry unknown risks if used outside laboratory context because identity, impurities, sterility and degradation products still matter.
